from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2029c/pfkB

LFCtreatmentdescriptionclass of inhibitor

-0.138

Amikacinug/mL Amikacintranslation

-0.321

Cap5-10ug/mL Capreomycintranslation

-0.142

Rox10-50 ug/mL Roxithromycintranslation

-0.703

SM2-5 ug/mL Streptomycintranslation

-0.526

Tet5-10 ug/mL Tetracyclinetranslation

-0.325

Rif0.2-5ug/mL Rifampicintranscription

-0.185

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.014

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.405

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.691

CPZ10-50 ug/mL Chlorpromazinerespiration

0.840

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.292

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.480

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.182

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.317

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.146

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.659

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.045

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.594

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.498

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.492

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.146

Nigericin50 uM Nigericinrespiration

1.151

TRC10-150 ug/mL Triclosanrespiration

0.598

TRZ10-25 ug/mL Thioridazinerespiration

0.629

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.142

menadione6-10 ug/mL Menadionerespiration

-0.145

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.020

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.298

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.108

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

3.051

NRP_1Non-replicating persistence stage 1dosRassociated

-1.010

Amp0.2mg/mL AmpicillincellWall

-0.340

Cephalexin20-100 ug/mL CephalexincellWall

-0.192

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.656

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.657

EMB10-20 ug/mL EthambutolcellWall

-0.427

Eta12-40 ug/mL EthionamidecellWall

-0.587

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.491

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.756

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.516

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.480

BZA0.12 mg/mL BenzamidearomaticAmides

-0.710

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.497

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.307

H2O24 mM hydrogen peroxideDNAdamaging

-0.337

Levo10 ug/mL LevofloxacinDNAdamaging

-0.671

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.579

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.757

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.769

UVUV-irradiationDNAdamaging

-0.168

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.277

Antimycin12.5-50 ug/mL Antimycin A?

-0.056

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.249

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.157

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.450

PA8240.2-2 ug/mL PA-824?

2.569

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.382

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

2.383

Verapamil50 uM Verapamil?

-0.291

mercaptoethanol2 mM 2-Mercaptoethanol?

0.022

methoxatin10-20 ug/mL Methoxatin?